Results 161 to 170 of about 301,296 (304)

Venous Thromboembolism and Associated Factors in Hospitalized Patients with COVID-19 at Addis Ababa COVID-19 Field Hospital, Ethiopia

Abel Teklit Haile,1,2 Robel Gemechu Haile,1– 3 Esrom Hagos Gebrehiwot,1– 3 Eden Workalemahu Abeje1– 3 1Research Department, Saint Peter Specialized Hospital, Addis Ababa, Ethiopia; 2Department of Internal Medicine, Wollo University, Dessie, Ethiopia ...
Haile RG, Haile AT, Gebrehiwot EH, Abeje EW   +3 more
core  

Systemic Therapy Management Strategies for Early‐Stage Breast Cancer in Australia

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Advances in systemic therapy for early‐stage breast cancer in Australia highlight genomic‐guided decisions, subtype‐specific strategies, and emerging targeted and immunotherapies, shaping personalized and de‐escalated treatment approaches. ABSTRACT Breast cancer is the most common cancer among Australian women, with early‐stage disease (Stages I, II ...
Nicholas Zdenkowski, Rachel Dear, Sanjeev Kumar, Hilary Martin, Dhanusha Sabanathan, Stephen J. Luen, Belinda Yeo   +6 more
wiley   +1 more source

Venous thromboembolism in paediatrics [PDF]

BJA Education, 2019
S, Jinks, A, Arana
openaire   +2 more sources

Peri‐operative management of patients having day surgery: a consensus statement from the Association of Anaesthetists, British Association for Day Surgery and the Association of Paediatric Anaesthetists, Great Britain and Ireland

Anaesthesia, EarlyView.
Summary Introduction Day surgery is now recognised widely as being a vital component of modern healthcare delivery with overall day surgery rates in the UK now > 85%. Day surgery offers an enhanced experience for patients with reduced risk of postoperative complications (e.g.
Craig R. Bailey, David Bunting, Lindsay Hudman, Shivan Kanani, Kirstin May, Catalina Stendall, Rachel Tibble, Allan Xu, Matthew D. Wiles   +8 more
wiley   +1 more source

Etiology and management of venous thromboembolism recurrence in patients anticoagulated for venous thromboembolism: a single-center study. [PDF]

Res Pract Thromb Haemost
Brunton N, Wysokinski WE, Hodge DO, Vlazny DT, McBane RD, Houghton DE, Casanegra AI.   +6 more
europepmc   +1 more source

Prospective Short‐ and Long‐Term Changes in Cardiometabolic Risk Markers Following Gender‐Affirming Hormone Therapy

Andrology, EarlyView.
ABSTRACT Introduction Gender‐affirming hormone therapy (GAHT) may be associated with increased cardiometabolic disease (CMD) risk. Prospective CMD risk screening is recommended, but long‐term data are needed regarding changes in CMD markers. Objectives To evaluate prospective changes in CMD risk markers during GAHT.
Louise Lehmann Christensen, Camilla Viola Palm, Marianne S. Andersen, Guy T'Sjoen, Jan Frystyk, Tine Taulbjerg Kristensen, Rikke Hjortebjerg, Dorte Glintborg   +7 more
wiley   +1 more source

Pulmonary Embolism—A Century of Progress

ANZ Journal of Surgery, EarlyView.
Reviews a century of progress in the diagnosis, prevention, and management of pulmonary embolism; from the first successful surgical embolectomy in 1924 to advanced imaging, pharmacological thromboprophylaxis, and treatment. In the 21st century, advances include catheter‐directed thrombolysis or mechanical thrombectomy under decision‐making guidance of
D. A. Watters
wiley   +1 more source

Prevention of Venous Thromboembolism in Patients With Pancreatic Cancer: A Nationwide Survey. [PDF]

Cancer Med
Willems RAL, Graus MUJE, van Gansewinkel EHE, van Diepen AE, Cirkel GA, van Laarhoven HWM, Wumkes ML, Homs MYV, Wilmink JW, Klok FA, van Es N, Ten Cate H, de Vos-Geelen J, Dutch Pancreatic Cancer Group (DPCG).   +13 more
europepmc   +1 more source

Topical Tranexamic Acid in Breast Surgery: A Systematic Review and Meta‐Analysis of Postoperative Bleeding Outcomes

ANZ Journal of Surgery, EarlyView.
Study evaluated the effectiveness and safety of topical tranexamic acid in breast surgery. Topical TXA reduced postoperative haematoma risk by 75% and significantly decreased postoperative drain output compared with controls, while seroma rates were unchanged.
Sina Sobhanmanesh, Femi E. Ayeni, Deborah S. M. Cheung   +2 more
wiley   +1 more source

Beyond Anticoagulant Exposure: Determinants of Mortality After Gastrointestinal Bleeding Across DOAC, Warfarin and Non‐Anticoagulated Patients

Alimentary Pharmacology &Therapeutics, EarlyView.
Among 11,387 patients with acute gastrointestinal bleeding, overlap‐weighted analyses (n = 10,044) found no statistically significant association between direct oral anticoagulant or warfarin use and 30‐day or 1‐year mortality. Haemodynamic shock was associated with 30‐day mortality, whereas age and Internal Medicine ward admission were associated with
Esther Forkosh, David Hakimian, Harold Jacob, Ian M. Gralnek, Lior Katz, Aviv Talmon   +5 more
wiley   +1 more source